Queensland University of Technology (QUT) has recently installed one of the world's most powerful nanotechnology microscopes. The only one if its kind in Australia, the Zeiss Orion NanoFab enables researchers to examine natural or manmade structures in incredible detail and will create new insights wherever it is applied. [ + ]

Agenix (ASX:AGX) and Scotland's Arrayjet have teamed up to develop a platform capable of conducting multiplexed affinity-based assays. [ + ]

Three young female scientists were this week awarded the 2013 L'Oréal for Women in Science Fellowships. One such scientist was Dr Misty Jenkins, who was recognised for her work in understanding whether cancer cells emit a 'distress call' when under lethal attack from healthy T cells. [ + ]

Mesoblast's (ASX:MSB) recent $170m capital raising allowed the company to close out FY13 with total available funds of $315m. [ + ]

The Sydney Neuroimaging Analysis Centre, located with the Brain and Mind Research Institute in Sydney, is now home to some sophisticated neuroimaging technology previously unavailable in Australia. [ + ]

Further to the notice of the forthcoming election for the board of directors of AusBiotech for 2013-14, nominations are now open for eligible AusBiotech members. [ + ]

Ununpentium is the interim name for the latest super-weight to have its existence confirmed (but not yet acknowledged) - element 115. [ + ]

Measurement company Agilent Technologies has announced the opening of its new Spectroscopy Technology Innovation Centre in Mulgrave, Victoria. The $25 million centre houses cutting-edge research and testing laboratories, as well as user demo and training facilities. [ + ]

The Coalition has formally released its agricultural policy, which promises to allocate $100 million to research and development in the sector. [ + ]

Pharmaxis (ASX:PXS) will cut back on resources dedicated to a launch of CF treatment Bronchitol in France, due to delays reaching agreement with the CEPS on reimbursement. [ + ]

Nanosonics (ASX:NAN) director Michael Kavanagh will take over as CEO from October, with current chief Ron Weinberger moving into a new role. [ + ]

A higher R&D tax benefit in FY13 helped Calzada (ASX:CZD) narrow its loss for the FY13 financial year to $1.5m. [ + ]

Genetic Technologies (ASX:GTG) has arranged to place an extra $800k in shares to sophisticated investors, and to increase the underwriting for its planned SPP to $1.8m. [ + ]

Three early-career scientists have been awarded $25,000 one-year fellowships. [ + ]

Nanosonics has tapped senior Cochlear executive Michael Kavanagh to become its next CEO. Kavanagh will take the roles of CEO and president effective 21 October. [ + ]